[b]Arthritis drug market still dominated by NSAIDs[/b]

Mumbai, India – May 5, 2014 - A disease of the joints, arthritis results in the wear and tear of the joints, rendering patients incapable of painless movement. As a result the joints become inflamed causing pain and discomfort. Though the primary symptoms of the
disease remains the same there are different varieties of the disease like the rheumatoid arthritis in which immune system affects the joints, and osteoarthritis that degenerates the joints further.

With the increase in obesity, arthritis has simultaneously become a common phenomenon wherein one in every 5 adults in USA is diagnosed with the problem. Furthermore, because of the sedentary lifestyles and unhealthy living, this number is expected to reach 67 million by 2030, in USA alone.

In order to provide a relief from the severity of the disease, the drug manufacturers developed a drug known as the non-steroidal anti-inflammatory drugs (NSAIDs) that interfere with the prostaglandins chemicals within the body, which causes the pain, inflammation and fever. Arthritis market research reveals that there are some NSAIDs drugs that are available over the counter including the ibuprofen, aspirin and naxproxen, which curb the inflammation, however, a prescription may be needed from the doctor. Though the NSAID drugs relieve pain and swelling in all types of arthritis including gout, however, arthritis review reports state that the drugs have serious side effects like stomach bleeding and increased risk for cardiovascular complications.

The arthritis drug market is still dominated by the biological drugs, especially proteins that help in blocking the tumor necrosis factor. The drug legislations further prevent generic versions which drop the level of the competition in the market. On the other hand, branded arthritis treatments are also threatened, as these over the counter drugs are cheaper and easily accessible. Moreover, there are some concerns with the available drugs because of the high probability of serious side effects like cancer in children and adolescents. Thus, the healthcare fraternity is researching new drugs that come with new mechanisms to cure the disease without the harmful side effects which are likely to create a new wave of pharmaceutical drugs in the arthritis treatment market.

[b]For further insights[/b], Arthritis Market

[b]About Research on Global Markets[/b]

Research on Global Markets is a leading sce for market research on various sectors globally, offering premium research content from worldwide publishers of market research reports. Our database hosts premium market research content developed by global publishers. It offers premium industry research reports, company profiles and country briefs. We have a dedicated team of research professionals who can facilitate, in an unbiased manner, the process of identifying appropriate market research reports that are targeted to fulfill all your information-related requirements.

For more details on the content of each report and ordering information please contact:

[b]Phone:[/b] US/CAN: +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
[b]E-Mail:[/b] [email protected]
[b]Related links:[/b] www.blog.researchonglobalmarkets.com